Overview
Clinical Benefits
- Broad antimicrobial activity
- Destroys biofilms
- Wound healing
- Immune defense enhancement
Administration
Subcutaneous injection near infection site when applicable
Drug class: cathelicidin
Clinical Dosing
Typical dosage
50-100mcg
Starting dose
50mcg
Cadence
Once daily
Full titration schedule
| Phase | Dose |
|---|---|
| Weeks 1-2 | 50mcg daily |
| Weeks 3+ | 50-100mcg daily for 4-6 weeks |
Safety Profile
Side effects
- • Injection site irritation
- • Redness
Contraindications
- • Pregnancy
- • Autoimmune conditions (caution)
Frequently asked questions
LL-37 is most commonly researched for: Broad antimicrobial activity, Destroys biofilms, Wound healing, Immune defense enhancement.
Ready to build a protocol with LL-37?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.